The FDA’s power to approve drugs faces sweeping challenge in lawsuit seeking to pull abortion pill from U.S. market

Posted on AllSides January 24th, 2023
From The Center
Healthcare, Abortion Pills, FDA, Lawsuit
Robyn Beck | AFP | Getty Images

The Food and Drug Administration is squaring off with anti-abortion physicians in an unprecedented legal challenge to its more than two-decade-old approval of a pill used to terminate early pregnancies.

The Alliance for Hippocratic Medicine asked a federal district court in Dallas late last year to declare the FDA approval unlawful and completely remove the abortion pill from the U.S. market.

The case has thrust the FDA in the middle of the fierce national battle over abortion access in the wake of the Supreme Court’s decision to overturn Roe v....

Read full story
Some content from this outlet may be limited or behind a paywall.

CNBC

AllSides Media Bias Rating: Center
AllSides Media Bias Rating: Center
111382/86444
See full bias rating for CNBC
Learn about media bias
https://www.cnbc.com/2023/01/24/abortion-pill-fda-challenged-in-lawsuit-seeking-to-pull-mifepristone-from-us.html

More News about Healthcare from the Left, Center and Right

From the Left

From the Center

From the Right